The global androgen deprivation therapy market continues to gain momentum as prostate cancer remains one of the most prevalent cancers among men worldwide. Androgen deprivation therapy (ADT) is a cornerstone in the treatment of hormone‑sensitive prostate cancer, helping to slow tumor progression by reducing androgen levels or blocking androgen effects. Market dynamics are shaped by...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt